ABL Bio Inc (298380)

Currency in KRW
241,500
-2,000(-0.82%)
Closed·
Trading near 52-week High
298380 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
231,000257,500
52 wk Range
31,300257,500
Key Statistics
Bid/Ask
241,500.00 / 242,000.00
Prev. Close
243,500
Open
241,000
Day's Range
231,000-257,500
52 wk Range
31,300-257,500
Volume
1.86M
Average Volume (3m)
1.37M
1-Year Change
584.136%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
298380 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
124,500
Downside
-48.45%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

ABL Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

ABL Bio Inc Company Profile

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company offers ABL301, which is in the phase 1 clinical stage for the treatment of parkinson’s disease; ABL503 and ABL111 that is in phase 1 clinical stage for the treatment of solid tumor; and ABL102 for the treatment of solid and blood tumor. It also provides ABL103 for the treatment solid cancers; ABL104 for the treatment of solid tumor; and ABL105, which is in phase 1 clinical stage for the treatment of solid tumor. ABL Bio Inc. was incorporated in 2016 and is based in Seoul, South Korea.

Compare 298380 to Peers and Sector

Metrics to compare
298380
Peers
Sector
Relationship
P/E Ratio
−474.4x−16.8x−0.6x
PEG Ratio
−10.56−0.240.00
Price/Book
74.6x3.8x2.6x
Price / LTM Sales
153.7x19.7x3.4x
Upside (Analyst Target)
−61.3%6.3%42.5%
Fair Value Upside
Unlock1.4%5.0%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 124,500
(-48.45% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 11, 2025
EPS / Forecast
-395.00 / -101.20
Revenue / Forecast
1.44B / --
EPS Revisions
Last 90 days

298380 Income Statement

People Also Watch

435,000
196170
+6.62%
240,500
086280
-0.21%
572,000
010120
+6.52%
441,000
307950
-0.45%
307,000
108490
+5.86%

FAQ

What Is the ABL Bio (298380) Stock Price Today?

The ABL Bio stock price today is 241,500

What Stock Exchange Does ABL Bio Trade On?

ABL Bio is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for ABL Bio?

The stock symbol for ABL Bio is "298380."

What Is the ABL Bio Market Cap?

As of today, ABL Bio market cap is 13.42T.

What Is ABL Bio's Earnings Per Share (TTM)?

The ABL Bio EPS (TTM) is -575.68.

From a Technical Analysis Perspective, Is 298380 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has ABL Bio Stock Split?

ABL Bio has split 0 times.

How Many Employees Does ABL Bio Have?

ABL Bio has 102 employees.

What is the current trading status of ABL Bio (298380)?

As of Jan 28, 2026, ABL Bio (298380) is trading at a price of 241,500, with a previous close of 243,500. The stock has fluctuated within a day range of 231,000 to 257,500, while its 52-week range spans from 31,300 to 257,500.

What Is ABL Bio (298380) Price Target According to Analysts?

The average 12-month price target for ABL Bio is KRW124,500, with a high estimate of KRW210000 and a low estimate of KRW80000. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -48.45% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.